INIS
inflammation
100%
diseases
74%
patients
63%
proteins
62%
lipopolysaccharides
62%
levels
47%
humans
46%
lungs
43%
receptors
27%
control
25%
tumor necrosis factor
25%
plasma
23%
mice
22%
increasing
22%
blood
21%
interleukins
20%
permeability
19%
production
18%
comparative evaluations
18%
c-reactive protein
18%
surgery
17%
genes
16%
endotoxins
15%
tobacco smokes
14%
cytokines
14%
leptin
13%
matrices
12%
walls
11%
metabolism
10%
asthma
10%
Keyphrases
Chronic Obstructive Pulmonary Disease
56%
Lipopolysaccharide
40%
Tumor Necrosis Factor-α
35%
Systemic Inflammation
29%
Interleukin-6
25%
Lipopolysaccharide-binding Protein
24%
Inflammatory Mediators
23%
C-reactive Protein
23%
Bactericidal/permeability-increasing Protein
21%
Lung
19%
Inflammation
15%
LPS-binding Protein
14%
Local Inflammation
14%
TNF Receptor 1 (TNFR1)
13%
Leptin
13%
Interleukin-8
13%
Cigarette Smoking
13%
Hyaluronan
12%
Endotoxin
12%
Soluble CD14 (sCD14)
11%
Inflammatory Response
11%
Maastricht
11%
Systemic Inflammatory Response
10%
Resting Energy Expenditure
10%
Acute Phase Proteins
10%
Plasma Parameters
9%
Epithelial Cells
9%
Inflammatory Markers
9%
Acute Exacerbation of COPD (AECOPD)
9%
Netherlands
9%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
38%
Inflammatory Mediator
22%
Lipopolysaccharide Binding Protein
19%
Lipopolysaccharide
17%
Serositis
17%
Lung
17%
C Reactive Protein
12%
Interleukin 6
12%
Acute Phase Protein
11%
Resting Energy Expenditure
10%
Leptin
10%
Endotoxin
10%
Sputum
10%
Tumor Necrosis Factor Receptor
9%
Bactericidal Permeability Increasing Protein
8%
Tumor Necrosis Factor
8%
Protein Binding
8%
Small Cell Lung Cancer
6%
Cardiopulmonary Bypass
6%
Elective Surgery
6%
Non Small Cell Lung Cancer
6%
Epithelial Cell
6%
Diseases
5%
Mediator
5%
Acute Phase Response
5%
